Oral detection test for cannabinoid use

• US 7,816,143 B2
• Filed: 11/13/2008
• Issued: 10/19/2010
• Est. Priority Date: 11/03/2004
• Status: Active Grant

• Current Assignee: Labone Incorporated (Quest Diagnostics Incorporated)
• Original Assignee: Labone Incorporated (Quest Diagnostics Incorporated)
• Inventors: Day, David, Kuntz, David J., Feldman, Michael S.
• Primary Examiner(s): Wallenhorst; Maureen M
• Application Number:
  US12/270,782
• Publication Number:
  US 20090159792A1
• Time in Patent Office: 705 Days
• Field of Search: 436/63, 436/161, 436/173, 436/169, 436/901, 436/93, 210/656, 250/281, 250/282, 250/283
• US Class Current: 436/93
• CPC Class Codes: G01N 33/948 Sedatives, e.g. cannabinoids, barbiturates opiates G01N33/9486
• CPC Class Codes: Y10S 436/901 Drugs of abuse, e.g. narcotics, amphetamine
• CPC Class Codes: Y10T 436/142222 Hetero-O [e.g., ascorbic acid, etc.]
• CPC Class Codes: Y10T 436/24 Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Abstract

A method for confirming the active intake of marijuana and its active component Δ⁹-tetrahydrocannabinol (“Δ⁹-THC”) by detecting the amount of 11-nor-Δ⁹-THC carboxylic acid (“THCA”) in oral fluid at the picogram per milliliter (pg/ml) level using chromatography/mass spectrometry/mass spectrometry (“GC/MS/MS”).

Claims

1. A method for quantifying the amount of 11-nor-Δ

⁹-THC carboxylic acid (“

THCA”

) in an oral fluid sample comprising the steps of;

providing an oral fluid sample;

ionizing any THCA present in the oral fluid sample under conditions suitable to produce one or more ions detectable by mass spectrometry, wherein said one or more ions detectable by tandem mass spectrometry comprise a THCA parent ion with a mass to charge ratio (m/z) of 620.5 or one or more THCA fragment ions selected from the group of ions with mass to charge ratio (m/z) of 492 and 383;

determining the amount of said one or more ions by tandem mass spectrometry; and

using the amount of said one or more ions to determine the amount of THCA in the sample.

2. The method of claim 1, wherein the tandem mass spectrometry is gas chromatography/mass spectrometry/mass spectrometry (GC/MS/MS).

3. The method of claim 1, wherein said THCA undergoes a negative chemical ionization.

4. The method of claim 3, wherein an internal standard is added to said sample prior to mass spectrometry.

5. The method of claim 4, wherein said internal standard is THCA-d3.

6. The method of claim 5, wherein said THCA-d3 is ionized under conditions suitable to produce one or more THCA-d3 parent ions, wherein at least one of said THCA-d3 parent ions has a mass to charge ratio (m/z) of 623.5.

7. The method of claim 6, wherein said at least one of said THCA-d3 parent ions is fragmented into one or more THCA-d3 products ions and at least one of said THCA-d3 product ions has a mass to charge ratio (m/z) of 495 or 386.

8. The method of claim 1, wherein the amount of THCA detected in said oral fluid sample is less than about 240 pg/ml.

9. The method of claim 1, wherein said oral fluid sample is obtained from a test subject using a collection pad which is placed in the oral cavity of said test subject.

10. The method of claim 9, wherein said pad is impregnated with one or more of a preservative, protein binding blocking agent, or detergent.

11. The method of claim 9, further comprising the step of storing the oral fluid sample in a preservative solution prior to said detecting step.

12. The method of claim 9, further comprising the step of extracting THCA and/or THCA-glucuronide from the collection pad using one or more organic reagents.

13. The method of claim 9, further comprising the step of extracting THCA and/or THCA-glucuronide from the pad using an aqueous reagent mixture.

14. A method for quantifying the amount of 11-nor-Δ

⁹-THC carboxylic acid (“

THCA”

) in a sample comprising the steps of;

providing a sample;

purifying any THCA present in the sample by solid phase extraction;

ionizing the purified THCA from the sample under conditions suitable to produce one or more THCA ions detectable by mass spectrometry;

determining the amount of one or more THCA ions by tandem mass spectrometry; and

using the amount of said one or more THCA ions to determine the amount of THCA in the sample;

wherein said one or more THCA ions determined by tandem mass spectrometry comprise at least one THCA parent ion with a mass to charge ratio (m/z) of 620.5 and one or more THCA fragment ions selected from the group of ions with mass to charge ratio (m/z) of 492 and 383.

15. The method of claim 14, wherein said sample comprises oral fluid.

16. The method of claim 14, wherein the tandem mass spectrometry is gas chromatography/mass spectrometry/mass spectrometry (GC/MS/MS).

17. The method of claim 14, wherein an internal standard is added to said sample prior to mass spectrometry.

18. The method of claim 17, wherein said internal standard is THCA-d3.

19. The method of claim 18, wherein said THCA-d3 is ionized under conditions suitable to produce at least one or more THCA-d3 parent ions, wherein at least one of said THCA-d3 parent ions has a mass to charge ratio (m/z) of 623.5.

20. The method of claim 19, wherein said at least one of said THCA-d3 parent ions is fragmented into one or more THCA-d3 products ions and at least one of said THCA-d3 product ions has a mass to charge ratio (m/z) of 495 or 386.

21. A method for determining the amount of isotopically labeled 11-nor-Δ

⁹-THC carboxylic acid (“

THCA”

) in a sample, said method comprising;

providing a sample containing isotopically labeled THCA;

ionizing said isotopically labeled THCA under conditions suitable to produce one or more ions detectable by mass spectrometry;

determining the amount of one or more isotopically labeled THCA ions by tandem mass spectrometry; and

using the amount of said one or more isotopically labeled THCA ions to determine the amount of said isotopically labeled THCA in the sample;

wherein said one or more isotopically labeled THCA ions determined by tandem mass spectrometry comprise at least one isotopically labeled THCA parent ion having a mass to charge ratio (m/z) of 623.5, and one or more isotopically labeled THCA fragment ions.

22. The method of claim 21, wherein said isotopically labeled THCA is THCA-d3.

23. The method of claim 22, wherein at least one of said isotopically labeled THCA fragment ions has a mass to charge (m/z) ratio of 495 or 386.

24. The method of claim 21, wherein said isotopically labeled THCA is purified by solid phase extraction prior to ionization.